Cargando…
Tuberous Sclerosis Complex cell‐derived EVs have an altered protein cargo capable of regulating their microenvironment and have potential as disease biomarkers
Hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) is a feature of many solid tumours and is a key pathogenic driver in the inherited condition Tuberous Sclerosis Complex (TSC). Modulation of the tumour microenvironment by extracellular vesicles (EVs) is known to facilitate the de...
Autores principales: | Bhaoighill, Muireann Ní, Falcón‐Pérez, Juan M., Royo, Félix, Tee, Andrew R., Webber, Jason P., Dunlop, Elaine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279809/ https://www.ncbi.nlm.nih.gov/pubmed/37337371 http://dx.doi.org/10.1002/jev2.12336 |
Ejemplares similares
-
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
por: Bhaoighill, Muireann Ní, et al.
Publicado: (2019) -
EV Cargo Sorting in Therapeutic Development for Cardiovascular Disease
por: Sherman, Cherrie D., et al.
Publicado: (2021) -
Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment
por: McCann, Henry D., et al.
Publicado: (2018) -
Impact of Storage Conditions on EV Integrity/Surface Markers and Cargos
por: Sivanantham, Ayyanar, et al.
Publicado: (2022) -
Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop
por: Russell, Ashley E., et al.
Publicado: (2019)